It has been reported that metformin or AICAR attenuates Ang II-induced atheromatous plaque formation and protects against hyperglycemia-induced atherosclerosis (Li et al., 2010; Vasamsetti et al., 2015; Wang et al., 2017) and also reduces insulin resistance (Yang et al., 2012). The gene discussed is AGT; the disease is atherosclerosis.